Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
about
Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Genomic mutation-driven metastatic breast cancer therapy: a single center experiencePrognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.Genomic alterations in neuroendocrine cancers of the ovary.PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian PatientsCurrent companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the piePIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.A simple and robust real-time qPCR method for the detection of PIK3CA mutations.Validation of differentially methylated microRNAs identified from an epigenome-wide association study; Sanger and next generation sequencing approaches
P2860
Q31114379-C2E31448-9F9F-440A-A443-5F0EDDCE7F21Q33688687-2F204903-D96A-4ACE-ACB4-AC83C6C4F42FQ36070010-1ADD93DC-4266-45A5-B0E0-04A460F66386Q36264188-C31BC8A6-625D-4D81-92CE-3EE2E16A13E7Q37212060-C9934A55-E507-4CF4-A2D3-15B8FDF4CD9FQ38752902-B40C9E94-7ED6-4B48-929A-284BF7337A30Q39172118-46BEB60E-3DE0-44B4-A7CB-90AC27B5B013Q39767744-BFB852E9-05E9-4E6D-BDEA-6D4A814794DAQ48191288-24FF429F-A5F7-4CD8-90B5-3E23B6FD38C9Q51711213-99BC2EB7-20F9-4159-9CAA-7625D9A9229BQ52727509-423AD8E3-D289-4B63-8C68-6829006AD0CBQ58101380-BF1F50FF-79BF-4326-BE45-CBF562C5CC9B
P2860
Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@ast
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@en
type
label
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@ast
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@en
prefLabel
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@ast
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@en
P2093
P2860
P1476
Comparison of targeted next-ge ...... 3CA mutations in breast cancer
@en
P2093
Annika Lehmann
Carsten Denkert
Denise Treue
Jan Budczies
Michael Hummel
Ruza Arsenic
P2860
P2888
P356
10.1186/S12907-015-0020-6
P577
2015-11-18T00:00:00Z
P5875
P6179
1001944773